Emerging Approaches for Patient-Centric Formulation and Therapy Delivery
14:55 - 15:30
The next decade is poised to witness an explosion in new approaches to treat grievous human illness, especially in oncology.
These approaches include new modalities and combinations of existing therapies
One aspect for the pharmaceutical industry to focus on would be on improving the experience of patients
This talk will cover emerging therapeutic delivery approaches to enhance the patient experience, including decreasing injection pain, reducing visits to healthcare clinics and hospitals, as well as converting medicines to more tolerable routes of administration
Dr. Rahul Rajan Kaushik is a 15-year leader at Amgen, where he is a Director of Process Development, accountable for process, formulation and delivery for 7 Amgen pipeline programs across a variety of modalities including synthetics, antibodies, bispecific T-cell engagers and drug conjugates, via a group of scientists and engineers. Rahul has played a key role in enabling pharmaceutical development and regulatory approval for multiple key Amgen products in the market today. He helped establish external partnerships for process development and clinical manufacturing, and led the team that established an end to end, state of the art pilot facility. He has led cross-functional teams delivering significant outcomes in lifecycle management initiatives related to patient centric product presentations, with a particular focus on Oncology. He holds an undergraduate degree in Chemistry from I.I.T. Bombay, first in graduating class (top 20 out of 100,000 applicants) and recipient of the J.N.Tata endowment. Following this, he obtained a full scholarship to pursue a Ph.D. at Stanford University, which he completed in the field of cell biology, furthering our understanding of the Ubiquitin Proteasome Pathway which is implicated in Oncology and neurodegenerative disorders. He is an author of numerous publications, patents, book chapters, review articles and is a frequently invited speaker for eminent conferences in the industry.